Concepedia

Chamandi S. Dampalla

CS

Statistics

Publications

8

Citations

273

H-Index

8

Active since

2020

Affiliations

New York Structural Biology Center(Current)

University of Kansas

Kansas State University

Wichita State University

University of Iowa

Chamandi S. Dampalla is an author at New York Structural Biology Center specializing in medicinal chemistry, antiviral pharmacology, and virology.

ORCID

Publications per year

2020–2023

8

Publications

8

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

Chamandi S. Dampalla, Jian Zheng, Krishani Dinali Perera et al. · Proceedings of the National Academy of Sciences · 2021 · 79 citations · Full text

, , +17

Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease

Chamandi S. Dampalla, Yunjeong Kim, Naemi P. Bickmeier et al. · Journal of Medicinal Chemistry · 2021 · 59 citations · Full text

, , +16

Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease

Chamandi S. Dampalla, Athri D. Rathnayake, Anushka C. Galasiti Kankanamalage et al. · Journal of Medicinal Chemistry · 2022 · 38 citations · Full text

, , +15

Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies

Chamandi S. Dampalla, Athri D. Rathnayake, Krishani Dinali Perera et al. · Journal of Medicinal Chemistry · 2021 · 32 citations · Full text

, , +17

Post-infection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

Chamandi S. Dampalla, Jian Zhang, Krishani Dinali Perera et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 19 citations · Full text

, , +17

1–5 of 8